wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50078364-78958A7E-9276-486C-8A02-CF609000E77B
Q50078364-78958A7E-9276-486C-8A02-CF609000E77B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50078364-78958A7E-9276-486C-8A02-CF609000E77B
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.
P2860
Q50078364-78958A7E-9276-486C-8A02-CF609000E77B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50078364-78958A7E-9276-486C-8A02-CF609000E77B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00a93e8c49a0468977d09f0d14c378bb627d5faf
P2860
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplan